Part ofhealthcare →

FEDERALhearing transcript

High Impact

Congressional Hearing on the Proposed CVS Health and Aetna Merger

Original title: THE PHARMACEUTICAL SUPPLY CHAIN: THE PROPOSED MERGER OF CVS HEALTH AND AETNA

January 1, 2018

healthcare antitrust mergers pharmaceuticals CVS Health Aetna

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

The Frame

What this does

The hearing examined whether the merger of a major pharmacy chain and a health insurer would reduce competition, potentially impacting healthcare costs and access to services for millions of Americans.

Who is mentioned in the record

Potentially affected actors named in the source documents. Mention is not a position.

CVS Health

The company is a party to the proposed merger under review by the subcommittee.

Aetna, Inc.

The company is a party to the proposed merger under review by the subcommittee.

Healthcare consumers

Consumers may experience changes in access to pharmacy services and insurance coverage depending on the outcome of the merger.

What changed

Last recorded activity January 1, 2018.

What's next

Next step not available in the current record.

Summary

This document is the official transcript record of a 2018 House Judiciary Subcommittee hearing regarding the potential competitive impact of the proposed merger between CVS Health and Aetna. The hearing featured testimony from company executives, economists, and consumer advocates to examine how the consolidation might affect the .

Key Facts

The hearing took place on February 27, 2018, in the Rayburn House Office Building.
The Subcommittee on Regulatory Reform, Commercial and Antitrust Law held the hearing to review the proposed merger between CVS Health and Aetna.
Testimony was provided by representatives from CVS Health and Aetna, as well as academic experts and consumer advocates.
The hearing focused on the pharmaceutical supply chain and potential antitrust implications of the merger.
The record includes opening statements from Chairman Tom Marino and Ranking Members David Cicilline and Jerrold Nadler.

Why It Matters

Frequently Asked Questions

What was the purpose of this hearing?

The hearing was held to examine the proposed merger between CVS Health and Aetna and its potential impact on competition within the .

Who testified at the hearing?

Witnesses included executives from CVS Health and Aetna, economists from Northwestern University and NERA Economic Consulting, and representatives from the Consumer Union and the International Center for Law and Economics.

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Discoveries

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift90% confidence

Healthcare Consolidation Oversight

The hearing highlights the increased congressional focus on vertical integration within the healthcare sector during the 115th Congress.

CVS Health Aetna

Connected Entities

personThomas J. Sabatino, Jr.“Executive Vice President and General Counsel, Aetna, Inc.”Map →

organizationHouse Committee on the Judiciary“The committee overseeing the subcommittee hearing.”Map →

personTom Marino“Chairman of the Subcommittee on Regulatory Reform, Commercial and Antitrust Law.”Map →

organizationCVS Health“Company proposing a merger with Aetna.”Map →

personDavid Cicilline“Ranking Member of the Subcommittee.”Map →

organizationAetna, Inc.“Company proposing a merger with CVS Health.”Map →

personThomas M. Moriarty“Executive Vice President and General Counsel, CVS Health.”Map →

Sources

Open source document

www.govinfo.gov

Analysis Score

0–100

Significance85
How much this matters to a regular citizen
Controversy60
Intensity of disagreement among stakeholders
Entertainment20
Compellingness for a non-policy-wonk reader
Buzz10
Current news / social attention level

Publisher tools